About

Publications

Koyasu, S., Minor, H. A., Asiedu, K. O., Choyke, P. L., & Sato, N. (2025). Zirconium-89-Oxine Cell Tracking by PET Reveals Preferential Monocyte Recruitment to Cancer and Inflammation over Macrophages. Pharmaceuticals,18(6), 897. https://doi.org/10.3390/ph18060897.

Nyong, E., Yutaka Kurebayashi, Asiedu, K. O., Choyke, P. L., & Sato, N. (2025). Intracellular Protein Binding of Zr-89 Oxine Cell Labeling for PET Cell Tracking Studies. Pharmaceutics, 17(4), 518–518. https://doi.org/10.3390/pharmaceutics17040518.

Hazell, S. Z., Hu, C., Alcorn, S. R., Asiedu, K. O., Pulido, G., Frassica, D. A., Meyer, C., Levin, A. S., Morris, C. D., & Terezakis, S. A. (2020). Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas. Advances in Radiation Oncology, 5(2), 231–237. https://doi.org/10.1016/j.adro.2019.08.015.

Asiedu, K. O., Munira Ferdousi, Ton, P. T., Adler, S. S., Choyke, P. L., & Sato, N. (2018). Bone marrow cell homing to sites of acute tibial fracture: 89Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model. EJNMMI Research, 8(1), 109–109. https://doi.org/10.1186/s13550-018-0463-8.

Asiedu, K. O., Sho Koyasu, Szajek, L. P., Choyke, P. L., & Sato, N. (2016). Bone Marrow Cell Trafficking Analyzed by 89Zr-oxine Positron Emission Tomography in a Murine Transplantation Model. Clinical Cancer Research, 23(11), 2759–2768. https://doi.org/10.1158/1078-0432.ccr-16-1561.

Sato, N., Wu, H., Asiedu, K. O., Szajek, L. P., Griffiths, G. L., & Choyke, P. L. (2015). ⁸⁹Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies. Radiology, 275(2), 490–500. https://doi.org/10.1148/radiol.15142849

Additional Research Experience 

National Institutes of Health: Bethesda, MD 6/2013-8/2015
Molecular Imaging Program -National Cancer Institute
Postbaccalaureate Research Fellow 

• Evaluated and optimized the use of PET and SPECT radionuclide agents for cell labeling and in vivo cell imaging using a MicroPET and MicroSPECT/CT in murine models. 
• The underlying rationale was to apply knowledge gained in this endeavor to improve cell-based cancer immunotherapy. 

National Institutes of Health: Bethesda, MD 6/2012-8/2012
Section on Genetic Disorders and Metabolism-NICHD
Summer Research Intern 

• The lab focused on characterizing the isozymes known as uridine-diphosphate glucuronosyltransferases (UGTs), which are found primarily in steroidogenic tissues and act in the excretion of lipophilic compounds, such as steroid hormones. 
• My project was to determine the impact that a prostate-specific UGT had on prostate tumorigenesis through its known role in removing dihydrotestosterone and whether it also interacted with the tumor suppressor protein, NKX3.1.